A double-blind clinical trial of fenfluramine in the treatment of obesity. - Suppr | 超能文献

A double-blind clinical trial of fenfluramine in the treatment of obesity.

作者信息

Sainani G S, Fulambarkar A M, Khurana B K

出版信息

Br J Clin Pract. 1973 Apr;27(4):136-8.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

A double-blind clinical trial of fenfluramine in the treatment of obesity.

Br J Clin Pract. 1973 Apr;27(4):136-8.

2

A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.一项关于体重控制的双盲临床试验。单独及联合使用芬氟拉明和苯丁胺。

Arch Intern Med. 1984 Jun;144(6):1143-8.

3

A double-blind clinical trial of fenfluramine.芬氟拉明的双盲临床试验。

Br J Clin Pract. 1972 Feb;26(2):79-82.

4

[Treatment of obesity with fenfluramine (Ponderal)].用芬氟拉明（苯氟雷司）治疗肥胖症

Ugeskr Laeger. 1973 Sep 3;135(36):1932-7.

5

Double-blind cross-over study of fenfluramine (Ponderax) in obesity.芬氟拉明（Ponderax）治疗肥胖症的双盲交叉研究。

J Assoc Physicians India. 1972 Nov;20(11):849-52.

6

[The therapeutic effect of Fenfluramine on body weight in overweight patients. A controlled clinical study].

Tidsskr Nor Laegeforen. 1973 Dec 30;93(35):2545-9.

7

[The effect of Ponderal in patients with refractory overweight].

Tidsskr Nor Laegeforen. 1973 Dec 30;93(35):2541-5.

8

Metabolic effects of fenfluramine--a double-blind study.芬氟拉明的代谢效应——一项双盲研究。

Postgrad Med J. 1975;51 Suppl 1:139-44.

9

[Clinical trial of a new long-acting fenfluramine in the treatment of obesity].一种新型长效芬氟拉明治疗肥胖症的临床试验

G Clin Med. 1978 Nov;59(11):486-510.

10

Fenfluramine in the management of obesity.芬氟拉明在肥胖症治疗中的应用。

Br J Clin Pract. 1973 Oct;27(10):373-5.

引用本文的文献

1

Drug interventions for the treatment of obesity in children and adolescents.用于治疗儿童和青少年肥胖症的药物干预措施。

Cochrane Database Syst Rev. 2016 Nov 29;11(11):CD012436. doi: 10.1002/14651858.CD012436.

2

Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.芬氟拉明：对其药理特性及在肥胖症治疗中的疗效综述。

Drugs. 1975;10(4):241-323. doi: 10.2165/00003495-197510040-00001.